Skip to main content

Over 150 years later, the boardwalk remains the heart of Atlantic City, New Jersey

Now 156 years old, Atlantic City's boardwalk is the oldest and longest in the country

Click here for updates on this story

    Philadelphia (KYW) — From souvenir shops to restaurants, casinos and hotels, many people consider the boardwalk the heart of Atlantic City, New Jersey.

“I enjoy walking around, looking at the stands, the beach,” Erminie Pennisi said.

“Seeing the birds fly, the people, the food,” Cynthia Lewis said.

“You got the ocean. You see all types of people from all walks of life,” Joseph Smith said.

Generations of families, visitors and vacationers have been walking the boards, soaking in the sights and experiencing a key piece of Atlantic City’s history.

“Everything that used to be and everything that is, is based around the boardwalk,” Heather Perez, an Atlantic County historian, said.

This summer marks 156 years of the Atlantic City Boardwalk. The first section of the boardwalk opened on June 26, 1870.

Perez says Atlantic City was becoming a popular summer resort, and the idea for the first wooden walkway all started with keeping sand out of railroad cars and hotels.

“The hotel owners were frustrated because the women in their long Victorian gowns were tracking all of this sand into the lobbies and they were trying to sweep and get all the sand out of their carpets and their floors,” Perez said.

At that time, the boardwalk was only 1 mile long and 8 feet wide, and it could be taken apart and preserved during the winter.

But as the city grew in popularity, so did the boardwalk. In 1898, Steel Pier opened, which became a venue for entertainment and excitement.

“I do think that they saw opportunity here. It’s a place people could come on vacation,” Danielle Osakwe, archivist at the Atlantic City Free Public Library, said.

In 1921, the Miss America pageant was founded, a major event held in Atlantic City for decades that helped extend the tourism season. Later came the casinos, and the boardwalk’s popularity over the years has led to new attractions and businesses.

“It’s had so much influence. It’s been the inspiration for a lot of different things around the country, but it’s still here and it’s still going on. I just think that’s pretty neat,” Osakwe said.

Today, the Atlantic City boardwalk stretches a little more than 5 miles long. Some businesses have come and gone, but the boardwalk is still bustling with activity. Steel Pier still entertains families, and the wooden walkway remains a tradition for many families.

“We just have a super time. There’s lots to do on the boardwalk,” Larry Zimmerman said.

“You cannot have Atlantic City without the boardwalk. It’s tied together,” Perez said.

Please note: This story was provided to CNN Wire by an affiliate and does not contain original CNN reporting. This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.

Personalized mRNA cancer vaccine shows promise in extending lifespan in melanoma trial

Stock photo of a doctor examining a patient's skin. (Lordhenrivoton/STOCK PHOTO/Getty Images)(NEW YORK) -- Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.The individualized vaccine, when paired with the existing immunotherapy, Keytruda, is the first and only combination regimen that demonstrated success in potentially extending melanoma patients' lifespans.In Phase 3 trials, the regimen significantly reduced the risk of cancer returning or spreading. The trial was conducted among patients whose high-risk melanoma had been surgically removed.The combination treatment regimen pairs the personalized vaccine with Merck's Keytruda, which had previously been used to treat the cancer alone.The treatment showed a 49% reduction of melanoma return after patients underwent surgery and a 59% reduction of metastasization of the cancer to distant organs.Key questions surrounding regulatory review of the vaccine remain.The Food and Drug Administration has not yet approved the vaccine. The agency will review the full data once it has been collected and submitted.While the FDA has already approved other cancer vaccines, this new treatment represents a step forward in the field as it uses mRNA technology and personalized treatment for each patient.Merck and Moderna plan to present data at an upcoming international medical meeting where they hope to engage regulators on filing submissions for approval of the regimen, the companies said in a joint press release.Dr. Ahmad Tarhini, an oncologist at the H. Lee Moffitt Cancer Center & Research Institute, told ABC News that he expects the treatment to be approved based on very positive trial results and made available to patients likely by early 2027.The vaccine uses genetic information from patients' individual tumors to identify and attack the cancer."It's what we call individualized neoantigen therapy, where we take the cancer itself, we do genetic sequencing and try to define a unique mutational fingerprint of the cancer itself," Tarhini said.Melanoma is the deadliest form of skin cancer, with about 112,000 new cases expected in 2026, according to the American Cancer Society.The treatment is considered relatively safe, according to the companies. The most common side effects include fatigue, sore arm and chills.Treatments utilizing mRNA technologies are being used in trials for other forms of cancer, including that of the bladder, kidney, lungs, stomach and pancreas, according to Tarhini."I think it will certainly improve the outcome of our patients," Tarhini said. "We are, you know, excited about this development. My expectation is this will eventually change the standard care of our patients."Copyright © 2026, ABC Audio. All rights reserved.
Read Next Story